4-[2-(4-chlorothiophen-2-yl)oxyacetyl]-3-(methoxymethyl)-1-[[4-(6-methoxy-3-pyridinyl)phenyl]methyl]piperazin-2-one

C25H26ClN3O5S — CID 57170574

IUPAC4-[2-(4-chlorothiophen-2-yl)oxyacetyl]-3-(methoxymethyl)-1-[[4-(6-methoxy-3-pyridinyl)phenyl]methyl]piperazin-2-one
SMILESCOCC1C(=O)N(Cc2ccc(-c3ccc(OC)nc3)cc2)CCN1C(=O)COc1cc(Cl)cs1
InChIInChI=1S/C25H26ClN3O5S/c1-32-14-21-25(31)28(9-10-29(21)23(30)15-34-24-11-20(26)16-35-24)13-17-3-5-18(6-4-17)19-7-8-22(33-2)27-12-19/h3-8,11-12,16,21H,9-10,13-15H2,1-2H3
InChIKeyISAAXJOTMHQBEZ-UHFFFAOYSA-N
MW516.02 g/mol
LogP3.74
Rot. Bonds9

About 4-[2-(4-chlorothiophen-2-yl)oxyacetyl]-3-(methoxymethyl)-1-[[4-(6-methoxy-3-pyridinyl)phenyl]methyl]piperazin-2-one

4-[2-(4-chlorothiophen-2-yl)oxyacetyl]-3-(methoxymethyl)-1-[[4-(6-methoxy-3-pyridinyl)phenyl]methyl]piperazin-2-one (PubChem CID 57170574) has the molecular formula C25H26ClN3O5S and a molecular weight of 516.02 g/mol. Its IUPAC name is 4-[2-(4-chlorothiophen-2-yl)oxyacetyl]-3-(methoxymethyl)-1-[[4-(6-methoxy-3-pyridinyl)phenyl]methyl]piperazin-2-one.

Molecular Properties

Compound Name4-[2-(4-chlorothiophen-2-yl)oxyacetyl]-3-(methoxymethyl)-1-[[4-(6-methoxy-3-pyridinyl)phenyl]methyl]piperazin-2-one
PubChem CID57170574
Molecular FormulaC25H26ClN3O5S
Molecular Weight516.02 g/mol
Exact Mass515.13
IUPAC Name4-[2-(4-chlorothiophen-2-yl)oxyacetyl]-3-(methoxymethyl)-1-[[4-(6-methoxy-3-pyridinyl)phenyl]methyl]piperazin-2-one
SMILESCOCC1C(=O)N(Cc2ccc(-c3ccc(OC)nc3)cc2)CCN1C(=O)COc1cc(Cl)cs1
InChIInChI=1S/C25H26ClN3O5S/c1-32-14-21-25(31)28(9-10-29(21)23(30)15-34-24-11-20(26)16-35-24)13-17-3-5-18(6-4-17)19-7-8-22(33-2)27-12-19/h3-8,11-12,16,21H,9-10,13-15H2,1-2H3
InChIKeyISAAXJOTMHQBEZ-UHFFFAOYSA-N
XLogP3.74
TPSA81.20 Ų
H-Bond Donors
H-Bond Acceptors7
Rotatable Bonds9
Heavy Atoms35
Complexity—

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500516.02
LogP ≤ 53.74
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 107

Analyze 4-[2-(4-chlorothiophen-2-yl)oxyacetyl]-3-(methoxymethyl)-1-[[4-(6-methoxy-3-pyridinyl)phenyl]methyl]piperazin-2-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 4-[2-(4-chlorothiophen-2-yl)oxyacetyl]-3-(methoxymethyl)-1-[[4-(6-methoxy-3-pyridinyl)phenyl]methyl]piperazin-2-one?
The IUPAC name of 4-[2-(4-chlorothiophen-2-yl)oxyacetyl]-3-(methoxymethyl)-1-[[4-(6-methoxy-3-pyridinyl)phenyl]methyl]piperazin-2-one (CID 57170574) is 4-[2-(4-chlorothiophen-2-yl)oxyacetyl]-3-(methoxymethyl)-1-[[4-(6-methoxy-3-pyridinyl)phenyl]methyl]piperazin-2-one.
What is the SMILES notation for 4-[2-(4-chlorothiophen-2-yl)oxyacetyl]-3-(methoxymethyl)-1-[[4-(6-methoxy-3-pyridinyl)phenyl]methyl]piperazin-2-one?
The canonical SMILES for 4-[2-(4-chlorothiophen-2-yl)oxyacetyl]-3-(methoxymethyl)-1-[[4-(6-methoxy-3-pyridinyl)phenyl]methyl]piperazin-2-one is COCC1C(=O)N(Cc2ccc(-c3ccc(OC)nc3)cc2)CCN1C(=O)COc1cc(Cl)cs1.
What is the InChIKey of 4-[2-(4-chlorothiophen-2-yl)oxyacetyl]-3-(methoxymethyl)-1-[[4-(6-methoxy-3-pyridinyl)phenyl]methyl]piperazin-2-one?
The InChIKey is ISAAXJOTMHQBEZ-UHFFFAOYSA-N. The full InChI is InChI=1S/C25H26ClN3O5S/c1-32-14-21-25(31)28(9-10-29(21)23(30)15-34-24-11-20(26)16-35-24)13-17-3-5-18(6-4-17)19-7-8-22(33-2)27-12-19/h3-8,11-12,16,21H,9-10,13-15H2,1-2H3.
What are the key properties of 4-[2-(4-chlorothiophen-2-yl)oxyacetyl]-3-(methoxymethyl)-1-[[4-(6-methoxy-3-pyridinyl)phenyl]methyl]piperazin-2-one?
4-[2-(4-chlorothiophen-2-yl)oxyacetyl]-3-(methoxymethyl)-1-[[4-(6-methoxy-3-pyridinyl)phenyl]methyl]piperazin-2-one has a molecular weight of 516.02 g/mol, XLogP of 3.74, 9 rotatable bonds, 0 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[2-(4-chlorothiophen-2-yl)oxyacetyl]-3-(methoxymethyl)-1-[[4-(6-methoxy-3-pyridinyl)phenyl]methyl]piperazin-2-one is sourced from PubChem (CID 57170574), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).